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    INTRODUCTION 1 
AIM: Improve the diagnostic protocol of canine PF  
using the human protocol as a model.  
How? 
1) To revise the sensibility and specificity of the sero-
logical tests used in the diagnosis of human PF. 
2) To study the correlation of the disease activity and 
the serum autoantibody levels in human patients. 
3) To analyse the existent studies about the use of se-
rological tests used in the diagnosis of canine PF.   
    HIPOTESIS AND OBJECTIVES 2 
    RESULTS 3 
      CONCLUSIONS 4 
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Table 1 
IIF sensibility in the diagnosis of human PF. Substrate influence 
in the results. 
Articles Sensibility Substrate 
[1] - ME and GPE;  Reactivity: GPE > ME 
[2] 86% ME and GPE;  Reactivity: GPE > ME 
[3] 71% ME and RL;  Reactivity: RL > ME 
[4] 
67% ME 
100% HS 
[5] 84% HS 
[6] 89% HS 
Table 2 ELISA sensibility and specificity in the diagnosis of human PF. 
Articles Sensibility Specificity rDsg-1* 
[6] 96% 96% Expressed in cultured insect cells, using a 
baculovirus as vector [7] 97,9% 98,9% 
[5] 92% 98,5% 
MESACUP Desmoglein TEST “Dsg-
1” (MBL) 
[4] 92% 99% 
[8] 
100% 95,7% 
96% 99,1% Human cell line (HEK293) expression 
Table 3 
Correlation of disease activity with serum autoantibody levels 
in human patients. 
Articles Patients 
Correlation disease 
activity - ELISA 
Substrate IIF 
Correlation disea-
se activity - IIF 
[6]  5 + HS + 
[7]  1 +     
[8]  5 + (p<0,001)     
[9] 2 +     
[10] 7 + (p=0,091) ME - 
[11] 9 - ME, RE, HS  + 
[12] 9 + ME + 
Abbreviations: ME (monkey oesophagus), GPE (guinea pig oesophagus), RL (rabbit lip), HS (human 
skin), RE (rat oesophagus), BT (bovine tongue), BE (bovine oesophagus), BN (bovine nose), CN 
(canine nose skin), CO (canine oral mucosa), MS (Neonatal mouse skin), CF (canine footpad), rDsg-1 
(recombinant Dsg-1), MCA-B1 (culture of canine oral acanthomatous epulis cell line) 
Table 4 
IIF sensibility in the diagnosis of canine PF. Substrate influence 
in the results. 
Articles  Substrate Sensibility Specificity 
[13] 
BT 64,3% 100%* 
BE 12,5% 100%* 
BN 0% 100% 
ME 44,4% 69% 
CN - 0% 
[14] 
BE 29,6% 83,9% 
CO 18,5% 93,5% 
MCA-B1 14,8% 100% 
[15] MS 82% 20% 
[16] MS 84% 20% 
[17] 
CF 100% - 
CO 18% - 
 
SEROLOGICAL TESTS IN HUMAN PF:  
 ELISA is the best serological test for the diagnosis of human PF. It 
provides higher sensibility and specificity than IIF, among other 
advantages. When performing IIF, the most indicated substrate 
is human skin.  
  Serological tests can become a useful tool to monitor the activi-
ty of the disease, but further investigation is required.  
SEROLOGICAL TESTS IN CANINE PF:  
  The studies conducted on the use of IIF for the diagnosis of ca-
nine PF hasn’t been very successful up to now.  
 Research on the usefulness of ELISA in the diagnostic protocol of 
this disease should be accomplished.  
 Pemphigus foliaceus (PF) is an autoimmune dis-
ease characterized  by the formation of superficial 
cutaneous blisters. It’s caused by the union of au-
toantibodies to desmosomal epithelial cadherins.  
 It’s rare in humans, but  is the most frequent au-
toimmune cutaneous disease in dogs. 
 The diagnostic protocol includes physical and his-
tologic exams in both species, and in humans it al-
so includes serological tests.  
